Showing results (141-150 of 181) with videos related to

Sort By:
Pageof 19
Cancer Research Communications|October 3, 2023
Immune-related Adverse Events after Immune Checkpoint Blockade-based Therapy Are Associated with Improved Survival in Advanced SarcomasEvan Rosenbaum, Kenneth Seier, Martina Bradic, et al.
Plos One|December 24, 2010
Equivalence of ELISpot assays demonstrated between major HIV network laboratoriesDilbinder K Gill, Yunda Huang, Gail L Levine, et al.
JCO Precision Oncology|December 7, 2020
Clinical Outcome of Leiomyosarcomas With Somatic Alteration in Homologous Recombination Pathway GenesEvan Rosenbaum, Philip Jonsson, Kenneth Seier, et al.
Investigational New Drugs|August 14, 2018
A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumorCiara M Kelly, Alexander N Shoushtari, Li-Xuan Qin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2023
PDGFRβ Signaling Cooperates with β-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type FibromatosisJia Hu, Meera R Hameed, Narasimhan P Agaram, et al.
European Journal of Cancer (Oxford, England : 1990)|August 24, 2024
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO/ARO/AIO-12 and the OPRA randomized phase 2 trialsEmmanouil Fokas, Hannah Williams, Markus Diefenhardt, et al.
The New England Journal of Medicine|July 12, 2018
Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG RevaccinationElisa Nemes, Hennie Geldenhuys, Virginie Rozot, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 1, 2023
Nonoperative management of the primary tumor in patients with unresectable stage IV colon cancer treated with systemic chemotherapy: Higher complication rates for left-sided colon tumorsFloris S Verheij, Jonathan B Yuval, Niels F M Kok, et al.
Nature Genetics|September 22, 2014
PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumorsWilliam Lee, Sewit Teckie, Thomas Wiesner, et al.
Cancer Research|August 5, 2020
Multiomic Analysis of Subtype Evolution and Heterogeneity in High-Grade Serous Ovarian CarcinomaLudwig Geistlinger, Sehyun Oh, Marcel Ramos, et al.
Pageof 19